In the United States, pancreatic cancer has the highest mortality rate among all major cancers, with a 5-year survival rate of only 11 percent. Diane M. Simeone, MD, director of the Pancreatic Cancer Center at 抖阴短视频 Health鈥檚 Perlmutter Cancer Center, serves as study chair for the , an international, multi-institutional collaborative group of experts that aims to increase the 5-year survival rate to 50 percent within the next 10 years. Early detection is the key to increasing survival for people with pancreatic cancer, but previous efforts were unable to succeed in a timely manner, Dr. Simeone tells The ASCO Post.
鈥淥ur goal is to enroll 10,000 participants, so we can meaningfully answer questions about risk factors, early detection, and prevention strategies,鈥 says Dr. Simeone, also the Laura and Isaac Perlmutter Professor of Surgery in the and professor in the at NYU Grossman School of Medicine. 鈥淲e view this as a platform to invite individuals with a diversity of expertise to work together to achieve our 50 percent survival rate goal. PRECEDE will drive advances in early detection, allowing studies to be performed, because there will be enough patients, data, and biospecimen samples to conduct them.鈥
Read more from .